Owen L. Woodman

Owen L. Woodman

Auto-generated profile, based on publicly available information

Owen L. Woodman

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences Monash University Melbourne Victoria Australia

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2010 in Molecular Pharmacology
Verified
Journal Article
Closed access
CKCassandra Koole
Cassandra Koole
DWDenise Wootten
Denise Wootten
JSJohn Simms
John Simms
CVCeline Valant
Celine Valant
RSRohan Sridhar
Rohan Sridhar
PSPatrick M Sexton
Patrick M Sexton
The glucagon-like peptide-1 (GLP-1) receptor is a key regulator of insulin secretion and a major therapeutic target for treatment of diabetes. However, GLP-1 receptor function is complex, with multiple endogenous peptides that can interact with the receptor, including full-length (1-37) and truncated (7-37) forms of GLP-1 that can each exist in an amidated form and the related peptide oxyntomodulin. We have investigated two GLP-1 receptor allosteric modulators, Novo Nordisk compound 2 (6,7-dichloro2-methylsulfonyl-3-tert-butylaminoquinoxaline) and quercetin, and their ability to modify binding and signaling (cAMP formation, intracellular Ca(2+) mobilization, and extracellular signal-regulated kinase 1/2 phosphorylation) of each of the naturally occurring endogenous peptide agonists, as well as the clinically used peptide mimetic exendin-4. We identified and quantified stimulus bias across multiple endogenous peptides, with response profiles for truncated GLP-1 peptides distinct from those of either the full-length GLP-1 peptides or oxyntomodulin, the first demonstration of such behavior at the GLP-1 receptor. Compound 2 selectively augmented cAMP signaling but did so in a peptide-agonist dependent manner having greatest effect on oxyntomodulin, weaker effect on truncated GLP-1 peptides, and negligible effect on other peptide responses; these effects were principally driven by parallel changes in peptide agonist affinity. In contrast, quercetin selectively modulated calcium signaling but with effects only on truncated GLP-1 peptides or exendin and not oxyntomodulin or full-length peptides. These data have significant implications for how GLP-1 receptor targeted drugs are screened and developed, whereas the allosterically driven, agonist-selective, stimulus bias highlights the potential for distinct clinical efficacy depending on the properties of individual drugs.

1 September 2017 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
SBSara Baratchi
Sara Baratchi
KKKhashayar Khoshmanesh
Khashayar Khoshmanesh
OWOwen L. Woodman
Owen L. Woodman
SPSimon Potocnik
Simon Potocnik
KPKarlheinz Peter
Karlheinz Peter
PMPeter McIntyre
Peter McIntyre

25 November 2004 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
PDF file
OWOwen L Woodman
Owen L Woodman
ECElsa Ch Chan
Elsa Ch Chan

1 February 2000 in Journal of Cardiovascular Pharmacology
Verified
Journal Article
Closed access
ECElsa C. H. Chan
Elsa C. H. Chan
PPPatchareewan Pannangpetch
Patchareewan Pannangpetch
OWOwen L. Woodman
Owen L. Woodman
The mechanism of the relaxant action and the structure-activity relation of flavonols (fisetin, quercetin, and 3,3′, 4′-trihydroxyflavone) and flavones (apigenin, chrysin, and luteolin) were examined in rat isolated thoracic aorta. The control responses to flavonols and flavones were compared with responses observed after the removal of the endothelium or in the presence of the L-type Ca2+ channel blocker, nifedipine (10−7 M). The effects of flavonoids on contraction caused by the influx of extracellular Ca2+ and agonist-induced release of intracellular Ca2+ also were investigated. The flavones exhibited endothelium-independent vasorelaxation, whereas the removal of the endothelium significantly decreased the sensitivity of the relaxant responses to the flavonols without affecting the maximal relaxation. In the presence of nifedipine, the responses to apigenin, luteolin, and quercetin were significantly inhibited, but relaxation to chrysin, fisetin, and 3,3′, 4′-trihydroxyflavone was unaffected. All flavonols and flavones caused concentration-dependent inhibition of the contractile responses to exogenous application of Ca2+ and the release of intracellular Ca2+ stimulated by phenylephrine. Of the six flavonoids examined, 3,3′, 4′-trihydroxyflavone was the most potent when causing vasorelaxation or inhibition of contraction caused by the influx or release of Ca2+. In conclusion, these studies provide evidence that the hydroxyl substitution in the carbon 3 position that characterizes the flavonols is important in stimulating endothelium-dependent vasorelaxation, and the absence of hydroxyl substitution on the A phenolic ring enhances the relaxant action.

29 February 2008 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CQChengxue Qin
Chengxue Qin
XCXingqiang Chen
Xingqiang Chen
RHRichard A. Hughes
Richard A. Hughes
SWSpencer J Williams
Spencer J Williams
OWOwen L. Woodman
Owen L. Woodman

1 September 2005 in Journal of Cardiovascular Pharmacology
Verified
Journal Article
Closed access
OWOwen L Woodman
Owen L Woodman
WMWilliam F Meeker
William F Meeker
MBMirna Boujaoude
Mirna Boujaoude
We investigated the structure-activity relationships regarding vascular and antioxidant activity of a range of synthetic flavonols and flavones with 3 or fewer hydroxyl (OH) or methoxyl substitutions. The relaxant responses and ability of the flavones/flavonols to inhibit phenylephrine (PE)- and Ca2+-induced contraction was determined in rat isolated thoracic aorta. The ability of these compounds to reduce the level of superoxide and preserve endothelium-dependent relaxation in the presence of oxidative stress was also examined. Four compounds impaired contraction to PE or Ca2+, in the potency order 3′-hydroxyflavonol > 3′,4′-dihydroxyflavonol > 7,4′-dihydroxyflavonol > 3′,4′-dihydroxyflavone. Flavonol, 3′,4′-dimethoxyflavonol, and flavone were significantly less active. The flavonoids caused concentration-dependent reductions in superoxide produced by rat aorta in the presence of NADPH. The most active compounds, 3′,4′-dihydroxyflavonol and 7,4′-dihydroxyflavonol, preserved endothelium-dependent relaxation in the presence of oxidative stress caused by pyrogallol or xanthine/xanthine oxidase. The results indicate that the catechol group is not critical for vascular relaxant or antioxidant activity, but rather, the important determinants for higher vascular and antioxidant activity of these compounds are the presence of a C3 OH group and the total number of OH substituents, respectively. These results have allowed the identification of the structural characteristics that promote vascular and antioxidant activity of flavonols, which may lead to the development of agents useful in treatment of cardiovascular disease.